Total Lab Automation Market

Total Lab Automation Market Size (2022 to 2027)

The global total lab automation market size is projected to grow at a CAGR of above 8.02% during the forecast period and be worth USD 7,258.9 million by 2027 from USD 4,935.7 million in 2022.

Total Lab Automation Market Share Insights:

• The growing need for brand-spanking new drug discovery through automation, rising demand for higher accuracy, and an increasing number of prominent players getting into strategic partnerships are expected to act favorably on the market’s growth rate.
• Based on type, the equipment segment accounted for the major share of the total lab automation market in 2021.
• Based on application, the genomics segment had the leading share of the global market in 2021.
• Based on region, the North American region led the market in 2021.
• The European region is anticipated to be valued at USD 2101 million by 2027.
• The Asia-Pacific region is expected to grow at a CAGR of 9.98% from 2022 to 2027.
• Thermo Fisher Scientific, Hudson Robotics, BD, Danaher, and Synchron Lab Automation are some prominent companies dominating the global total lab automation market.

Total Lab Automation represents an automation system employed to perform highly repetitive tasks conducted within the library. Total laboratory automation system performs the overall and esoteric laboratory testing throughout the system in a timely and cost-effective fashion. The biotechnology & pharmaceutical industries segment is the major revenue contributor due to the significant presence of pharmaceutical companies worldwide and an increase in robotics & laboratory automation adoption.

MARKET DRIVERS:

The high demand for automation in liquid handling and automated workstations offers advantages such as enhanced accuracy and reduced time. The price propels global total lab automation market growth.

To meet the rising demands of the healthcare industry, pharmaceutical and biotechnology companies are investing heavily in research and development activities, which is expected to promote the growth rate of the total lab automation market during the forecast period. For instance, pharmaceutical companies such as Sun Pharmaceuticals, Cipla, and Lupin Ltd. spent 8.8% of their revenue on R&D in 2018, according to the India Brand Equity Foundation (IBEF). Furthermore, partnerships between the pharmaceutical industry players for R&D in therapeutics are likely to fuel the global total lab automation market growth. In addition, growing demand for sample results, data integrity, short method development time, increasing healthcare expenditure, rising need for high efficiency, and low regent cost are expected to favor the growth of the total lab automation market.

Furthermore, the growing demand for higher accuracy within the testing results wiped out the laboratories, one of the major factors augmenting automation adoption within the laboratories. This is predicted to support the growth rate of the global total lab automation market over the forecast period. In addition, lab automation offers low regent cost, high productivity, reproducibility, and accuracy. These benefits also raise the demand for lab automation in various application sectors.

Emerging markets are expected to provide substantial growth opportunities for lab automation device manufacturers and distributors. Increased sales of lab automation products due to increased demand for clinical diagnostic procedures set new growth opportunities for the market. Major product manufacturers are expanding their distribution networks and manufacturing capacities in developing markets to grow their market share. This presents a profitable opportunity for laboratory automation. 

MARKET RESTRAINTS:

The high initial costs associated with lab automation, and the rigidity of the small and medium laboratories' to adapt to lab automation, are prominent restraining factors for the global total lab automation market. In addition, the cost of maintaining IT solutions is higher than the cost of the software itself. Furthermore, a lack of risk-taking capacity is limiting the growth of the total lab automation market.

In addition, the lack of skilled personnel and acceptance by small and medium-sized laboratories are anticipated to inhibit the market’s growth rate during the forecast period. Furthermore, because of the challenges of sharing data and communication standards between automated instruments from two separate organizations, the evolving nature of laboratory work necessitates automated solutions with greater versatility and interfacing capabilities. These factors are hindering the total lab automation market growth. 

Impact of COVID-19 on the global total lab automation market:

Medical facilities are in higher demand, along with the increasing number of COVID-19 patients. Respiratory support devices, including an atomizer, a life-support system, an oxygen generator, and a monitor, are among the most widely used medical devices in primary clinical care. COVID-19 has also significantly increased the demand for medical supplies such as personal protective equipment (PPE). In addition, the COVID-19 pandemic has increased drug development and research, thus putting excessive pressure on pharmaceutical companies and clinical laboratories.

On the other hand, the pandemic has resulted in lower profits and margins for hospitals and health systems and lower investments in automation and technology. In June 2020, a notable use case involving a Danish pipetting robot was identified, automating COVID-19 testing processes in hospitals across Europe. The Danish company Flow Robotics' liquid-handling robot has accelerated the process of COVID-19 tests. Thousands of COVID-19 tests are being prepared for analysis by Flow Robotics' advanced flow bot ONE daily. With these factors, the demand for the total lab automation market has increased enormously during the pandemic. 

REPORT COVERAGE:

This research report on the global total lab automation market has been segmented and sub-segmented based on the type, application, and region.

Total Lab Automation Market - By Type:

• Equipment
  • Automated Liquid Handlers
  • Automated Plate Handlers
  • Robotic arms
  • Automated storage and retrieval systems (ASRS)
• Software
  • Laboratory information management system (LIMS)
  • Laboratory information system (LIS)
  • Chromatography data systems (CDS)
  • Electronic lab notebook (ELN)
  • Scientific data management system (SDMS)

Based on type, the equipment segment is predicted to hold the most dominating share of the global total lab automation market during the forecast period and register the fastest growth owing to increased demand for automated laboratory equipment and technological advancements.

The software segment is projected to showcase a healthy CAGR during the forecast period; under the sub-segments, the laboratory information management system (LIMS) segment probably possesses an enormous demand in the future. A Laboratory Information Management System (LIMS) enables the user to automate work processes, integrate instruments, produce reliable outcomes rapidly, and improve effectiveness by sequencing information that runs over time and across experiments.

Total Lab Automation Market - By Application:

• Drug discovery
• Genomics
• Protein engineering
• Bio-analysis
• Analytical Chemistry
• Clinical diagnostics
• Proteomics

The genomics segment is predicted to showcase a healthy CAGR during the forecast period. The advances in genomics that deal with biology concerning the structure, function, evolution, and mapping of genomes create an abnormal amount of knowledge, making it imperative for laboratories to look for solutions that cater to such needs. This is expected to boost the genomic segment in the global market over the forecast period to account for a dominant share.

Total Lab Automation Market - By Region:

• North America
• Europe
• Asia-Pacific
• Latin America
• The Middle East and Africa

Geographically, the North American total lab automation market led the market in 2021 and is expected to continue the dominating trend throughout the forecast period. The regional dominance can be attributed to increased spending on medicinal services. In addition, the North American regional market is driven by the growing adoption of lab automation in executing the work practices by pharmaceutical companies, including clinical trials, where automation becomes imperative to urge error-free outcomes to achieve greater accuracy. For instance, in January 2019, Shimadzu Medical Systems USA announced ORE Medical Imaging, Inc. Therefore, in this region, the U.S. is forecasted to occupy the most dominating share during the forecast period.

The total lab automation market in the Asia-Pacific region is predicted to project faster growth during the forecast period due to emerging nations such as India, South Korea, Australia, and China, among others. This growth is attributed to the skilled workforce required within lab automation and improving economic conditions within the region.

On the other hand, the European market is expected to grow at a promising CAGR during the forecast period.

KEY MARKET PLAYERS:

Danaher Corporation, Hamilton Company, Honeywell International Inc., Shimadzu Corporation, Siemens AG, Thermo Fisher Scientific Roche Ltd, Qiagen Inc., Abbott Laboratories, and Agilent Technologies Inc. are a few companies playing a prominent role in the global total lab automation market and profiled in this report.

RECENT HAPPENINGS IN THIS MARKET:

• In Oct 2019, Danaher Corporation announced that it had signed a deal to sell its label-free biomolecular characterization, chromatography hardware and resins, and microcarriers and particle validation standards businesses Sartorius AG for about $750 million. The company's combined revenue, a part of Danaher's Life Sciences segment, was valued at around US$140 million in 2018. Danaher agreed to sell these businesses to obtain regulatory approval for its pending acquisition of the GE Biopharma business. Therefore, the closing of the Sartorius AG agreement is conditioned upon Danaher's closing of its acquisition of the GE Biopharma business.
• As a part of a partnership with Airbus, Hamilton developed two new sensors to be used onboard the International space platform. "VisiSpace," a custom version of Hamilton's VisiFerm dissolved oxygen sensor, and "ConduSpace," a custom version of the Conducell conductivity sensor, are incorporated into Airbus' Advanced closed-loop system System (ACLS) experimental life network.
• Hamilton Storage signed a deal with iBio-Gene on May 1, 2019, to distribute its automated sample management products in China. iBio-Gene is based in Beijing, with several staff and technicians located in China, including Shanghai. The company helps its customers augment life sciences research, solve complex analytical challenges, improve diagnostic methods, and increase laboratory productivity. The corporate is committed to providing the leading advanced science equipment and total solutions for patrons in biobanking. Their mission is to support customers in forming research that is accessible, reproducible, and consistent in every experiment.